Arkolith/Insider Trading/PEAR/Form 4

Brenner Erin K.

Chief Product Dev. OfficerPear Therapeutics, Inc. (PEAR) · full profile →Form 4 · filed Feb 17, 2023
No Open-Market Flow
Open-Market Buys
$0
Open-Market Sells
$0
Net Open-Market Flow
$0
Transactions
1
0 non-derivative · 1 derivative

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Feb 15, 2023Grant(A)952K—$0952K

Transaction Codes

A
Grant / award

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001062993-23-004044) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML